Characteristics and Mechanism of Acute Ischemic Stroke in NAVF Patients With Prior Oral Anticoagulant Therapy

被引:1
|
作者
Xue, Sufang [1 ]
Na, Risu [2 ]
Dong, Jing [1 ]
Wei, Min [1 ]
Kong, Qi [1 ]
Wang, Qiujia [1 ]
Qiu, Xue [3 ]
Li, Fangyu [1 ]
Song, Haiqing [1 ,4 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[2] Tongliao City Hosp, Dept Neurol, Tongliao, Peoples R China
[3] Shuangqiao Hosp, Dept Neurol, Beijing, Peoples R China
[4] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Changchun St 45, Beijing 100053, Peoples R China
关键词
prior oral anticoagulant therapy; acute ischemic stroke; nonvalvular atrial fibrillation; competing stroke mechanism; CAROTID-ARTERY STENOSIS; ATRIAL-FIBRILLATION; PREDICTING STROKE; SUBGROUP ANALYSIS; PREVENTION; WARFARIN; RISK; CLASSIFICATION; VALIDATION; RECURRENCE;
D O I
10.1097/NRL.0000000000000504
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We aimed to analyze the characteristics and mechanisms of acute ischemic stroke (AIS) in patients with nonvalvular atrial fibrillation (NVAF) who received prior anticoagulant therapy.Methods: We retrospectively analyzed the data of patients with NVAF and AIS between January 2016 and December 2021. Patients were divided into non-anticoagulant, adequate anticoagulant, and insufficient anticoagulant groups according to their prior anticoagulant status. Patients with prior anticoagulant therapy were further divided into warfarin and direct oral anticoagulant groups.Results: A total of 749 patients (661 without anticoagulants, 33 with adequate anticoagulants, and 55 with insufficient anticoagulants) were included. Patients with adequate anticoagulant had a milder National Institute of Health Stroke Scale at presentation (P=0.001) and discharge (P=0.003), a higher proportion of Modified Rankin Scale (mRS) <= 2 at discharge (P=0.011), and lower rates of massive infarction (P=0.008) than patients without anticoagulant. Compared with the non-anticoagulant group, the proportion of intravenous thrombolysis was significantly lower in the adequate anticoagulant (P<0.001) and insufficient anticoagulant (P=0.009) groups. Patients in the adequate anticoagulant group had higher rates of responsible cerebral atherosclerotic stenosis (P=0.001 and 0.006, respectively) and competing large artery atherosclerotic mechanisms (P=0.006 and 0.009, respectively) than those in the other 2 groups. Compared with warfarin, direct oral anticoagulant was associated with higher rates of Modified Rankin Scale <= 2 at discharge (P=0.003).Conclusions: Adequate anticoagulant therapy may be associated with milder stroke severity and better outcomes at discharge in patients with NVAF. Competing large artery atherosclerotic mechanisms may be associated with anticoagulant failure in patients with NAVF with prior adequate anticoagulant therapy.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 50 条
  • [21] Ischemic stroke in patients on oral anticoagulant therapy for a cardioembolic risk factor: always due to cardioembolism?
    Gino Gialdini
    Alberto Chiti
    Marta Gennaro
    Giovanni Orlandi
    Ubaldo Bonuccelli
    Neurological Sciences, 2013, 34 : 1703 - 1704
  • [22] Ischemic stroke in patients on oral anticoagulant therapy for a cardioembolic risk factor: always due to cardioembolism?
    Gialdini, Gino
    Chiti, Alberto
    Gennaro, Marta
    Orlandi, Giovanni
    Bonuccelli, Ubaldo
    NEUROLOGICAL SCIENCES, 2013, 34 (09) : 1703 - 1704
  • [23] Age, Weight, And Prior Stroke Predicts Ischemic Stroke Despite Direct Acting Oral Anticoagulant Use In Patients With Atrial Fibrillation
    Asad, Syed Daniyal
    De Oliveira, Lara Carvalho
    Ponciano, Ana
    Webb, Andrew J.
    Yilmaz, Pinar
    Anand, Viswanathan
    Singhal, Aneesh
    STROKE, 2023, 54
  • [24] Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
    Yan, Xiaodi
    Wang, Baoyan
    Xia, Peng
    Lan, Chen
    Wang, Qian
    Ge, Weihong
    Zhou, Yujie
    Jiang, Chenxiao
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [25] Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA
    S. Greisenegger
    S. Tentschert
    M. Weber
    J. Ferrari
    W. Lang
    W. Lalouschek
    Journal of Neurology, 2006, 253 : 648 - 652
  • [26] Antithrombotic Therapy in Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes
    Zhang, Dongfeng
    Song, Xiantao
    Chen, Yalei
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Henriques, Jose Paulo Simao
    D'Ascenzo, Fabrizio
    Saucedo, Jorge
    Gonzalez-Juanatey, Jose Ramon
    Wilton, Stephen B.
    Kikkert, Wouter J.
    Nunez-Gil, Ivan
    Ariza-Sole, Albert
    Alexopoulos, Dimitrios
    Liebetrau, Christoph
    Kawaji, Tetsuma
    Moretti, Claudio
    Huczek, Zenon
    Nie, Shaoping
    Fujii, Toshiharu
    Correia, Luis
    Kawashiri, Masa-aki
    Garcia-Acuna, Jose Maria
    Southern, Danielle
    Alfonso, Emilio
    Terol, Belen
    Garay, Alberto
    Xanthopoulou, Ioanna
    Osman, Neriman
    Moellmann, Helge
    Shiomi, Hiroki
    Giordana, Francesca
    Kowara, Michal
    Filipiak, Krzysztof
    Wang, Xiao
    Yan, Yan
    Fan, Jingyao
    Ikari, Yuji
    Nakahashi, Takuya
    Sakata, Kenji
    Yamagishi, Masakazu
    Kalpak, Oliver
    Kedev, Sasko
    ANGIOLOGY, 2020, 71 (06) : 576 - 577
  • [27] Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA
    Greisenegger, S.
    Tentschert, S.
    Weber, M.
    Ferrari, J.
    Lang, W.
    Lalouschek, W.
    JOURNAL OF NEUROLOGY, 2006, 253 (05) : 648 - 652
  • [28] Adherence to oral anticoagulant and antiplatelet therapies after an acute ischemic stroke or TIA in atrial fibrillation patients
    Riera-Arnau, Judit
    Sanfelix-Gimeno, Gabriel
    Liliana Rodriguez-Bernal, Clara
    Bejarano-Quisoboni, Daniel
    Hurtado, Isabel
    Garcia-Sempere, Anibal
    Peiro, Salvador
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 217 - 217
  • [29] Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy
    Partington, Sara L.
    Abid, Simona
    Teo, Koon
    Oczkowski, Wesley
    O'Donnell, Martin J.
    THROMBOSIS RESEARCH, 2007, 120 (05) : 663 - 669
  • [30] Ischemic stroke despite oral anticoagulant therapy in patients with AF: recurrence risk and optimal anticoagulation strategy
    Seiffge, D.
    De Marchis, G. M.
    Koga, M.
    Paciaroni, M.
    Wilson, D.
    Cappellari, M.
    Macha, K.
    Tsivgoulis, G.
    Ambler, G.
    Arihiro, S.
    Bonati, L.
    Bonetti, B.
    Kallmunzer, B.
    Muir, K.
    Bovi, P.
    Gensicke, H.
    Schwab, S.
    Yagi, S.
    Lyrer, P.
    Takagi, M.
    Jager, H. R.
    Polymeris, A.
    Toyoda, K.
    Engelter, S.
    Werring, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 49 - 49